Extended data Table 2: Kaplan Meier Log Rank data analysis shows significant worsening in the survival of patients with low ASS1 and high citrin expression levels in bladder cancer and lung adenocarcinoma.
The table shows the number of patients for which data was available in each group as well as the pair wise p-Value of comparison between the corresponding groups; BLCA- bladder cancer, BRCA- breast cancer, LUAD- lung adenocarcinoma, LUSC- lung squamous carcinoma.
| BLCA | Number of patients | ASS1 low only | Citrin high only | None | |
|---|---|---|---|---|---|
| ASS1 low Citrin high | 26 | 0.062029244 | 0.41802416 | 0.002920577 | |
| ASS1 low only | 437 | 0 | 0.939396939 | 0.133262071 | |
| Citrin high only | 83 | 0 | 0 | 0.397997761 | |
| None | 415 |
| BRCA | Number of patients | ASS1 low only | Citrin high only | None | |
|---|---|---|---|---|---|
| ASS1 low Citrin high | 25 | 0.091470414 | 0.348538412 | 0.215689269 | |
| ASS1 low only | 76 | 0 | 0.513641931 | 0.247876216 | |
| Citrin high only | 14 | 0 | 0 | 0.784222648 | |
| None | 90 |
| LUAD | Number of patients | ASS1 low only | Citrin high only | None | |
|---|---|---|---|---|---|
| ASS1 low Citrin high | 34 | 0.086250611 | 0.000771207 | 0.005978456 | |
| ASS1 low only | 16 | 0 | 0.989469401 | 0.778260123 | |
| Citrin high only | 181 | 0 | 0 | 0.440612674 | |
| None | 189 |
| LUSC | Number of patients | ASS1 low only | Citrin high only | None | |
|---|---|---|---|---|---|
| ASS1 low Citrin high | 56 | 0.889254024 | 0.131597923 | 0.271250284 | |
| ASS1 low only | 35 | 0 | 0.234416519 | 0.540649678 | |
| Citrin high only | 173 | 0 | 0 | 0.710240332 | |
| None | 127 |